GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ELAN · Mar 31, 2021

Elanco Animal Health Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001739104-21-000008General Corporate
Debt relative to revenue90thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.debt_to_revenue

496.05% · OPTIONAL · VALID

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.45% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generation44thOwn-history percentile · N=9
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

1.77% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

88.84% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure30thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

114.65% · OPTIONAL · VALID

Gross margin90thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.gross_margin

54.19% · CORE · VALID

R&D intensity0thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

7.17% · OPTIONAL · VALID

SBC intensity22thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.21% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
187.18%
Current
496.05%
Delta
308.88%
Capex Intensity Decreased
Previous
4.11%
Current
1.45%
Delta
-2.66%
Cash Generation Increased
Previous
-1.25%
Current
1.77%
Delta
3.02%
Growth Increased
Previous
6.59%
Current
88.84%
Delta
82.25%
Inventory Pressure Increased
Previous
48.21%
Current
114.65%
Delta
66.44%
Margin Increased
Previous
49.09%
Current
54.19%
Delta
5.10%
R And D Intensity Decreased
Previous
9.99%
Current
7.17%
Delta
-2.82%
Sbc Intensity Decreased
Previous
1.46%
Current
1.21%
Delta
-0.25%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ELAN Fundamental State →Has State · Elanco Animal Health Inc →Transitioned To · ELAN Fundamental State →Transitioned To · ELAN BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · ELAN CAPEX_INTENSITY_DECREASED →Transitioned To · ELAN CASH_GENERATION_INCREASED →Transitioned To · ELAN GROWTH_INCREASED →Transitioned To · ELAN INVENTORY_PRESSURE_INCREASED →Transitioned To · ELAN MARGIN_INCREASED →Transitioned To · ELAN R_AND_D_INTENSITY_DECREASED →Transitioned To · ELAN SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.